• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
insulin
replacement, T1DM always
tolbutamide, tolazamide, chlorpropamide, glyburide, glimepiride, glipizide
sulfonylureas
insulin secretagogues
close beta cell K+ channels causing depolarization and insulin release
replaginide, nateglinide
take before meals, closes K+ channels --> depol --> insulin release
Metformin
DOC for T2DM, prevents onset
increased glc uptake
decreased hepatic gluconeogenesis
does not produce hypoglycemia!
Rosiglitazone, Pioglitazone
thiazolidinedione
PPARgamma, alters gene expression
increased lipid storage, decreased TNFalpha, increased adiponectin
acarbose, miglitol
alpha glucosidase inhibitor
taken with meals, slows intestinal absorption of glucose
pramlintide
analog of amylin, slows GI absorption, reduces appetite, reduces glucagon secretion
Exenatide
GLP-1 incretin analog
increased insulin secretion, beta cell growth, decreased glucagon and appetite
Sitagliptin
DPP IV inhibitor, blocks degradation of endogenous incretins
Dapagliflozin
inhibits SGLT2 tubular glucose transporter which reabsorbs glc in nephron (increased glucose excretion)